Background A 43-year-old Caucasian man presented with enlarged right laterocervical lymph nodes, and a 6-month history of diarrhea and 9 kg weight loss. His previous medical history was unremarkable.

Please provide your email address to receive an email when new articles are posted on . The incidence of Kaposi’s sarcoma and related death in East Africa has not improved in the last 5 years. In a ...

Author(s)Amy Paturel, M.S., M.P.H. A rare virus coupled with an ailing immune system can lead to Kaposi’s sarcoma. Restoring immune function can help fight it. Alex C.* was a teenager in 2007 when ...

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study Over time, KS and NHL occurred at ...

The incidence of other malignancies before and after sarcoma diagnosis: A population-based study. A phase I/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R ...

Patients with HIV-negative Kaposi sarcoma (KS) can be successfully treated with immunotherapy even if they also have psoriasis or other skin conditions, according to a new case report. The paper ...

A study has identified a binding protein in cancer cell's nucleus, known as CHD4, as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune ...

The coronavirus disease (COVID-19) pandemic has devastated many countries, leaving more than a million people dead. Now ten months into the pandemic, more than 35.48 million people have been infected ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Pomalyst (pomalidomide; Celgene) for the treatment of patients with Kaposi sarcoma. The Food and Drug ...